glp-1 drugs for addiction GLP‑1 may fight across every major substance, according to a study of 600,000 people GLP-1 medications get at the
Description
doi: 10.1210/jc.2006-0587

doi: 10.1016/J.ECLINM.2024.102661 49 BettgeKKahleMAbd El AzizMSMeierJJNauckMA

Emerging research suggests these agents may reduce inflammatory markers such as C-reactive protein and pro-inflammatory cytokines through mechanisms independent of weight loss or glucose control

Microdosing is considered off-label use, or prescribing an approved drug for an unapproved use, which doctors are allowed to do if they deem it medically appropriate

sleeve gastrectomy and Roux-en-Y gastric bypass) and the increasingly popular GLP-1 Receptor Agonists (GLP-1 s)